KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Cash (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Change in Cash data on record, last reported at -$700.8 million in Q4 2025.

  • For Q4 2025, Change in Cash fell 1507.34% year-over-year to -$700.8 million; the TTM value through Dec 2025 reached $66.4 million, down 39.47%, while the annual FY2025 figure was $66.4 million, 39.47% down from the prior year.
  • Change in Cash reached -$700.8 million in Q4 2025 per ZBH's latest filing, down from $735.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $859.1 million in Q1 2025 and bottomed at -$827.7 million in Q2 2025.
  • Average Change in Cash over 5 years is -$10.5 million, with a median of -$35.2 million recorded in 2022.
  • The widest YoY moves for Change in Cash: up 3884.58% in 2025, down 3154.24% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$441.1 million in 2021, then soared by 61.53% to -$169.7 million in 2022, then soared by 172.83% to $123.6 million in 2023, then crashed by 135.28% to -$43.6 million in 2024, then tumbled by 1507.34% to -$700.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$700.8 million in Q4 2025, $735.8 million in Q3 2025, and -$827.7 million in Q2 2025.